| Product Code: ETC9974490 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Preventable Vaccines Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Preventable Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Preventable Vaccines Market - Industry Life Cycle |
3.4 United States (US) Preventable Vaccines Market - Porter's Five Forces |
3.5 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Preventable Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Preventable Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccinations for disease prevention |
4.2.2 Government initiatives promoting vaccination programs |
4.2.3 Technological advancements in vaccine development and administration |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy and misinformation leading to lower vaccination rates |
4.3.2 Regulatory challenges and approval processes for new vaccines |
4.3.3 High costs associated with vaccine production and distribution |
5 United States (US) Preventable Vaccines Market Trends |
6 United States (US) Preventable Vaccines Market, By Types |
6.1 United States (US) Preventable Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.1.5 United States (US) Preventable Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.6 United States (US) Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Preventable Vaccines Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Polio, 2021- 2031F |
6.2.5 United States (US) Preventable Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.6 United States (US) Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Preventable Vaccines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 United States (US) Preventable Vaccines Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United States (US) Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Preventable Vaccines Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Preventable Vaccines Market Import-Export Trade Statistics |
7.1 United States (US) Preventable Vaccines Market Export to Major Countries |
7.2 United States (US) Preventable Vaccines Market Imports from Major Countries |
8 United States (US) Preventable Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates among target populations |
8.2 Number of vaccinations administered annually |
8.3 Research and development investment in new vaccine technologies |
9 United States (US) Preventable Vaccines Market - Opportunity Assessment |
9.1 United States (US) Preventable Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United States (US) Preventable Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United States (US) Preventable Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Preventable Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 United States (US) Preventable Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Preventable Vaccines Market - Competitive Landscape |
10.1 United States (US) Preventable Vaccines Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Preventable Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here